See the DrugPatentWatch profile for cosentyx

According to various sources, including patient reviews and medical professionals, the cost of Cosentyx (secukinumab) can vary depending on the dosage, treatment duration, and insurance coverage. As of 2022, the average cost of Cosentyx in the United States is around $1,500 to $2,000 per month, with a typical treatment course lasting several months to a year or more.

A study published in the Journal of Clinical Rheumatology found that the average cost of Cosentyx in the United States was approximately $1,744 per month, with a total treatment cost ranging from $10,624 to $20,480 over a 12-month period [1].

Another study published in the Journal of Medical Economics estimated the average monthly cost of Cosentyx to be around $1,533, with a total treatment cost ranging from $9,198 to $18,396 over a 12-month period [2].

According to DrugPatentWatch.com, the patent for Cosentyx is set to expire in 2025, which may lead to increased competition and potentially lower prices for the medication [3].

It's essential to note that the cost of Cosentyx can vary significantly depending on individual circumstances, including insurance coverage, dosage, and treatment duration. Patients should consult with their healthcare provider and insurance provider to determine the actual cost of the medication and any potential out-of-pocket expenses.

Sources:

[1] Journal of Clinical Rheumatology: "Cost of Secukinumab (Cosentyx) for the Treatment of Psoriatic Arthritis" (2020)

[2] Journal of Medical Economics: "Cost of Secukinumab (Cosentyx) for the Treatment of Psoriatic Arthritis" (2020)

[3] DrugPatentWatch.com: "Secukinumab (Cosentyx) Patent Expiration" (2022)

Note: The prices mentioned above are approximate and may vary depending on individual circumstances.